European Pharmaceutical Review

DECEMBER 19, 2024

For] AI use in life sciences R&D… 2025 will see the industry enter the “plateau of enlightenment” AI use in life sciences R&D has now passed through most major stages of the Gartner Hype Cycle 2 and 2025 will see the industry enter the “plateau of enlightenment.” Internet] wh.gov.

Pharmaceutical 52

Pharmaceutical Ethics Medicine Pharma 52

Pharma Marketing Network

OCTOBER 17, 2024

As we approach 2025, the pharmaceutical industry is witnessing a seismic shift in marketing strategies, driven by technological advancements and evolving consumer expectations. However, the rise of influencer partnerships also necessitates careful consideration of ethical and regulatory guidelines.

Marketing 52

Marketing Healthcare Healthcare Pharma 52

Pharmaceutical Technology

DECEMBER 21, 2022

This could spell high-stake consequences for consumers whose privacy and safety could be at risk if AI models are not regulated. According to GlobalData, global AI revenues in the pharmaceutical, medical, and healthcare sectors are expected to reach almost $21 billion by 2025.

Pharma 140

Pharma Pharmaceutical Medicine Government 140

Pharmaceutical Technology

FEBRUARY 23, 2023

Most importantly, it gives more power to already influential tech giants and puts focus on the commercialization of biohacks rather than their health consequences or ethics. billion by 2025. Thus, we can see the technocratic rule of this age and the pervasiveness of tech hustle culture as driving biohacking.

Media 111

Media Healthcare Healthcare Ethics 111